XML 94 R54.htm IDEA: XBRL DOCUMENT v2.4.0.8
Stock-based Compensation (Details) (USD $)
3 Months Ended 9 Months Ended 3 Months Ended 9 Months Ended 3 Months Ended 9 Months Ended 3 Months Ended 9 Months Ended
Jun. 30, 2013
Jun. 30, 2013
Jun. 30, 2012
Jun. 30, 2013
Stock Options [Member]
Jun. 30, 2013
SSARs / Stock Options [Member]
Jun. 30, 2013
SSARs / Stock Options [Member]
Jun. 30, 2013
Nonvested Stock Awards [Member]
Sep. 30, 2012
Nonvested Stock Awards [Member]
Jun. 30, 2013
Performance Shares [Member]
Jun. 30, 2013
Nonvested Stock Awards and Performance Shares [Member]
Jun. 30, 2013
Nonvested Stock Awards and Performance Shares [Member]
Dec. 31, 2012
Nonvested Stock Awards and Performance Shares [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                        
Stock Surrendered During Period, Value   $ 121,000 $ 34,000                  
Total stock-based compensation included in general and administrative expenses 600,000 2,300,000                    
Total stock-based compensation included in general and administrative expenses, net of tax 500,000 1,800,000                    
Number of shares surrendered by emloyees (shares)   6,147 12,553                  
Intrinsic value of SSAR/stock options outstanding         1,400,000 1,400,000            
Aggregate intrinsic value of SSARs/stock options vested and expected to vest         1,400,000 1,400,000            
SSARs/stock options weighted average expected life         2 years 8 months 24 days              
Unrecognized compensation costs related to non-vested stock awards             1,400,000 2,100,000        
Number of shares of performance-based restricted stock issued (shares)                 31,532      
Weighted average period to recognize remaining cost             1 year 3 months 18 days          
Increase in target number of Performance Shares (percent)                 50.00%      
Non-vested stock performance period (years)                 3 years      
Expected dividend yield on performance shares (percent)                 0.00%      
Expected volatility rate range minimum (percent)                 35.60%      
Expected volatility rate range maximum (percent)                 60.40%      
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions [Abstract]                        
Expected life of options       5 years                
Expected volatility       46.15%                
Expected discrete dividends       0                
Weighted average risk-free interest rate       0.63%         0.34%      
Weighted average fair value       $ 5.48                
Share-based Compensation Arrangement by Share-based Payment Award, Outstanding [Roll Forward]                        
Shares outstanding at beginning of period (shares)         574,165 429,965            
Granted (shares)         $ 200,000 $ 200,000            
Exercised (shares)         (503) (608)            
Expired (shares)         0 (7,703)            
Forfeited (shares)         (763) (4,320)            
Shares outstanding at end of period (shares)         577,985 577,985            
Exercisable at end of period         325,396 325,396            
Vested or expected to vest in the future (shares)         574,752 574,752            
Share-based Compensation Arrangement by Share-based Payment Award, Outstanding, Weighted Average Exercise Price [Roll Forward]                        
Weighted average exercise price of shares outstanding at beginning of period         $ 32.75 $ 40.80            
Weighted average exercise price of shares granted         $ 20.58 $ 13.56            
Weighted average exercise price of shares exercised         $ 10.80 $ 10.80            
Weighted average exercise price of shares expired         $ 0.00 $ 96.45            
Weighted average exercise price of shares forfeited         $ 12.56 $ 17.86            
Weighted average exercise price of shares outstanding at beginning of period         $ 32.69 $ 32.69            
Weighted average exercise price of shares exercisable at end of period         $ 47.52 $ 47.52            
Weighted average exercise price of shares vested or expected to vest in the future         $ 32.79 $ 32.79            
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]                        
Shares outstanding at beginning of period (shares)                     323,335 374,753
Granted (shares)         5,086 160,651       6,104 99,413  
Shares vested (shares)                   (94,471) (126,124)  
Shares forfeited (shares)                   (3,615) (13,853)  
Shares outstanding at end of period (shares)                   282,771 282,771 374,753
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Roll Forward]                        
Weighted average grant date fair value of shares outstanding at beginning of period                     $ 19.61 $ 18.19
Weighted average grant date fair value of shares granted                 $ 5.02 $ 20.58 $ 10.95  
Weighted average grant date fair value of shares vested in period                   $ 33.22 $ 27.59  
Weighted average grant date fair value of shares forfeited in period                   $ 13.30 $ 13.92  
Weighted average grant date fair value of shares outstanding at end of period                   $ 13.29 $ 13.29 $ 18.19